Next Article in Journal
Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update
Next Article in Special Issue
Clinical Manifestations, Pathogenesis and Treatment of Hepatitis E Virus Infections
Previous Article in Journal
Obesity Does Not Increase the Risk of Asthma Readmissions
Previous Article in Special Issue
Isolated Anti-HBc: Significance and Management
Review

Targeting the Host for New Therapeutic Perspectives in Hepatitis D

1
Inserm, Institut de Recherche sur les Maladies Virales et Hépatiques UMR_S1110, Université de Strasbourg, F-67000 Strasbourg, France
2
Institut Hospitalo-Universitaire, Pôle Hépato-Digestif, Nouvel Hôpital Civil, F-67000 Strasbourg, France
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(1), 222; https://doi.org/10.3390/jcm9010222
Received: 20 December 2019 / Revised: 9 January 2020 / Accepted: 10 January 2020 / Published: 14 January 2020
Hepatitis D virus (HDV) is a small satellite virus of hepatitis B virus (HBV) requiring HBV infection to complete its life cycle. It has been recently estimated that 13% of chronic HBV infected patients (60 million) are co-infected with HDV. Chronic hepatitis D is the most severe form of viral hepatitis with the highest risk to develop cirrhosis and liver cancer. Current treatment is based on pegylated-interferon-alpha which rarely controls HDV infection and is complicated by serious side effects. The development of novel antiviral strategies based on host targeting agents has shown promising results in phase I/II clinical trials. This review summarizes HDV molecular virology and physiopathology as well as new therapeutic approaches targeting HDV host factors. View Full-Text
Keywords: Hepatitis D; antiviral strategy; host factors; liver disease Hepatitis D; antiviral strategy; host factors; liver disease
Show Figures

Figure 1

MDPI and ACS Style

Turon-Lagot, V.; Saviano, A.; Schuster, C.; Baumert, T.F.; Verrier, E.R. Targeting the Host for New Therapeutic Perspectives in Hepatitis D. J. Clin. Med. 2020, 9, 222. https://doi.org/10.3390/jcm9010222

AMA Style

Turon-Lagot V, Saviano A, Schuster C, Baumert TF, Verrier ER. Targeting the Host for New Therapeutic Perspectives in Hepatitis D. Journal of Clinical Medicine. 2020; 9(1):222. https://doi.org/10.3390/jcm9010222

Chicago/Turabian Style

Turon-Lagot, Vincent, Antonio Saviano, Catherine Schuster, Thomas F. Baumert, and Eloi R. Verrier 2020. "Targeting the Host for New Therapeutic Perspectives in Hepatitis D" Journal of Clinical Medicine 9, no. 1: 222. https://doi.org/10.3390/jcm9010222

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop